Fidelity International’s GSK GSK Stock Holding History

Fidelity International’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.5K	Buy	888 +8	+0.9%	+$423	﹤0.01%	1112
2026 Q1	$48.6K	Sell	880 -19	-2%	-$1.03K	﹤0.01%	1071
2025 Q4	$44.1K	Buy	899 +10	+1%	+$466	﹤0.01%	991
2025 Q3	$38.4K	Buy	889 +11	+1%	+$430	﹤0.01%	964
2025 Q2	$33.7K	Buy	878 +44	+5%	+$1.68K	﹤0.01%	955
2025 Q1	$32.3K	Buy	834 +12	+1%	+$439	﹤0.01%	889
2024 Q4	$27.8K	Sell	822 -13	-2%	-$468	﹤0.01%	896
2024 Q3	$34.1K	Buy	835 +142	+20%	+$5.81K	﹤0.01%	913
2024 Q2	$26.7K	Buy	693 +246	+55%	+$10.3K	﹤0.01%	878
2024 Q1	$19.2K	Buy	+447	New	+$18.4K	﹤0.01%	830

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Fidelity International's GSK Position: Q2 2026 in Review

Fidelity International increased its GSK (GSK) stake by 0.91% in Q2 2026, buying an estimated $423 and bringing the position to 888 shares worth $46.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Fidelity International first reported a position in GSK in Q1 2024 and has held it in 10 quarters since. The position peaked at $48.6K in Q1 2026. 909 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Fidelity International held 888 shares of GSK worth $46.5K as of Q2 2026.
Fidelity International bought 8 GSK shares in Q2 2026, an estimated $423.
GSK made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #1112 holding.
Fidelity International first reported a position in GSK in Q1 2024 and has held it in 10 quarters since.
Fidelity International's GSK position peaked at $48.6K in Q1 2026.
909 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.